Biotest AG (Biotest AG) Other Long-Term Liabilities : $472.8 Mil (As of Mar. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Biotest AG Other Long-Term Liabilities?

Biotest AG's other long-term liabilities for the quarter that ended in Mar. 2024 was $472.8 Mil.

Biotest AG's quarterly other long-term liabilities declined from Sep. 2023 ($699.0 Mil) to Dec. 2023 ($58.2 Mil) but then increased from Dec. 2023 ($58.2 Mil) to Mar. 2024 ($472.8 Mil).

Biotest AG's annual other long-term liabilities increased from Dec. 2021 ($10.5 Mil) to Dec. 2022 ($53.3 Mil) and increased from Dec. 2022 ($53.3 Mil) to Dec. 2023 ($58.2 Mil).

Biotest AG Other Long-Term Liabilities Historical Data

The historical data trend for Biotest AG's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biotest AG Other Long-Term Liabilities Chart

Biotest AG Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Long-Term Liabilities

Get a 7-Day Free Trial

Biotest AG Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Long-Term Liabilities	Get a 7-Day Free Trial															-	-	-	-	-

Biotest AG Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

Biotest AG Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Biotest AG's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Biotest AG (Biotest AG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biotest AG (OTCPK:BIESF) » Definitions » Other Long-Term Liabilities

Comparable Companies

Traded in Other Exchanges

BIO3:Germany BIO3:Austria

Address

Landsteinerstrasse 5, Dreieich, DEU, 63303

Website

https://www.biotest.com

Biotest AG is a supplier of biological medicines. The company produces its products from human blood plasma or manufactured by using biotechnology methods. It is engaged in the area of hematology, clinical immunology, and intensive care medicine. The operating business segments are Therapy, Plasma and Services, and Other segments. It generates maximum revenue from the Therapy segment. Geographically, it derives a majority of revenue from Central Europe and also has a presence in other countries.